Bank of New York Mellon’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-26,151
Closed -$36.9K 4194
2025
Q3
$36.9K Hold
26,151
﹤0.01% 4143
2025
Q2
$117K Hold
26,151
﹤0.01% 4056
2025
Q1
$119K Buy
26,151
+1
+0% +$6 ﹤0.01% 3980
2024
Q4
$159K Hold
26,150
﹤0.01% 3990
2024
Q3
$206K Hold
26,150
﹤0.01% 3897
2024
Q2
$293K Hold
26,150
﹤0.01% 3820
2024
Q1
$331K Hold
26,150
﹤0.01% 3735
2023
Q4
$359K Buy
+26,150
New +$306K ﹤0.01% 3726

Other funds holding BIOX

Bank of New York Mellon's BIOX Position: Q4 2025 in Review

Bank of New York Mellon sold out of Bioceres Crop Solutions (BIOX) in Q4 2025, closing a stake of 26,151 shares — an estimated $36.9K sold.

Bank of New York Mellon first reported a position in BIOX in Q4 2023 and held it in 8 quarters. The position peaked at $359K in Q4 2023. 37 funds tracked by Wall St. Rank hold BIOX as of Q4 2025.

  • Bank of New York Mellon reported no remaining Bioceres Crop Solutions position as of Q4 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 26,151 Bioceres Crop Solutions shares in Q4 2025, an estimated $36.9K.
  • Bank of New York Mellon first reported a position in Bioceres Crop Solutions in Q4 2023 and held it in 8 quarters.
  • Bank of New York Mellon's Bioceres Crop Solutions position peaked at $359K in Q4 2023.
  • 37 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q4 2025.

Based on Bank of New York Mellon's 13F filing for Q4 2025, filed 10 Feb 2026.